| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |